Clinical Trial Results:
Humoral and cellular immune response to COVID-19 vaccines in immunocompromised and healthy individuals – The CoVVac study
Summary
|
|
EudraCT number |
2021-001040-10 |
Trial protocol |
AT |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
30 May 2024
|
First version publication date |
30 May 2024
|
Other versions |
|
Summary report(s) |
Naïve B Cells as Predictors of Humoral Response to COVID 19 Altered cellular immune response to vaccination against SARS-CoV-2 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.